Millennium Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-159,224
Closed -$613K – 6770
2023
Q2
$613K Sell
159,224
-87,093
-35% -$320K ﹤0.01% 4401
2023
Q1
$744K Sell
246,317
-242,466
-50% -$838K ﹤0.01% 4340
2022
Q4
$1M Buy
488,783
+171,491
+54% +$523K ﹤0.01% 4167
2022
Q3
$1.1M Buy
317,292
+52,720
+20% +$240K ﹤0.01% 4257
2022
Q2
$1.11M Buy
264,572
+225,498
+577% +$533K ﹤0.01% 4264
2022
Q1
$119K Buy
39,074
+418
+1% +$1.6K ﹤0.01% 6069
2021
Q4
$180K Buy
38,656
+120
+0.3% +$826 ﹤0.01% 5983
2021
Q3
$297K Sell
38,536
-31,381
-45% -$240K ﹤0.01% 5823
2021
Q2
$601K Sell
69,917
-73,553
-51% -$649K ﹤0.01% 5139
2021
Q1
$1.63M Buy
+143,470
New +$2.25M ﹤0.01% 3726

Other funds holding DBTX

Millennium Management's DBTX Position: Q3 2023 in Review

Millennium Management sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 159,224 shares — an estimated $613K sold.

Millennium Management first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $1.63M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • Millennium Management reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Millennium Management sold 159,224 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $613K.
  • Millennium Management first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Millennium Management's Decibel Therapeutics, Inc. Common Stock position peaked at $1.63M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.